Additionally, low RHOB expression has been shown to correlate with a positive response to treatment with EGFR-tyrosine kinase inhibitors (EGFR-TKI) in EGFR-mutated lung cancer patients, and reversely high RHOB expression correlates with a poor response. This evidence concerns the gene EGFR and lung cancer.